132 related articles for article (PubMed ID: 8422014)
1. Progressive hemochromatotic cardiomyopathy despite reversal of iron deposition after liver transplantation.
Westra WH; Hruban RH; Baughman KL; Olson JL; Porterfield JK; Mitchell MC; Hutchins GM
Am J Clin Pathol; 1993 Jan; 99(1):39-44. PubMed ID: 8422014
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis.
Kuppahally SS; Hunt SA; Valantine HA; Berry GJ
J Heart Lung Transplant; 2006 Jan; 25(1):144-7. PubMed ID: 16399547
[TBL] [Abstract][Full Text] [Related]
3. Postshunt hemochromatosis leading to cardiogenic shock in a patient presenting for orthotopic liver transplant: a case report.
Hughes CG; Waldman JM; Barrios J; Robertson A
Transplant Proc; 2009 Jun; 41(5):2000-2. PubMed ID: 19545779
[TBL] [Abstract][Full Text] [Related]
4. Cardiac iron overload following liver transplantation in patients without hereditary hemochromatosis or severe hepatic iron deposition.
Papadodima S; Masia R; Stone JR
Cardiovasc Pathol; 2019; 40():7-11. PubMed ID: 30763826
[TBL] [Abstract][Full Text] [Related]
5. Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure.
Fenton H; Torbenson M; Vivekanandan P; Yeh MM; Hart J; Ferrell L
Transplantation; 2009 Apr; 87(8):1256-60. PubMed ID: 19384175
[TBL] [Abstract][Full Text] [Related]
6. Outcome of liver transplantation in patients with hemochromatosis.
Farrell FJ; Nguyen M; Woodley S; Imperial JC; Garcia-Kennedy R; Man K; Esquivel CO; Keeffe EB
Hepatology; 1994 Aug; 20(2):404-10. PubMed ID: 8045502
[TBL] [Abstract][Full Text] [Related]
7. Fatal Cardiac Hemochromatosis in a Patient with Hereditary Spherocytosis.
Fujino T; Inoue S; Katsuki S; Higo T; Ide T; Oda Y; Tsutsui H
Int Heart J; 2018 Mar; 59(2):427-430. PubMed ID: 29563373
[TBL] [Abstract][Full Text] [Related]
8. Refractory biventricular heart failure in secondary hemochromatosis.
Furth PA; Futterweit W; Gorlin R
Am J Med Sci; 1985 Nov; 290(5):209-13. PubMed ID: 4073117
[TBL] [Abstract][Full Text] [Related]
9. [Adiastole caused by a secondary cardiac hemochromatosis. Successful treatment with an iron chelating agent].
Baudouy P; Lombrail P; Azancot I; Piekarski A; Martin E; Slama R
Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1240-6. PubMed ID: 6418103
[TBL] [Abstract][Full Text] [Related]
10. [Cardiomyopathy in idiopathic hemochromatosis. Diagnostic possibilities using proton spin tomography].
Steudel A; Krahe T; Becher H; Steudel H
Dtsch Med Wochenschr; 1987 Apr; 112(15):590-2. PubMed ID: 3829947
[TBL] [Abstract][Full Text] [Related]
11. [Ventricular tachycardia and cardiac hemochromatosis].
Luis Moríñigo J; Martín Luengo C; Ledesma C; Arribas A; Nieto AA; Rodríguez J
Rev Esp Cardiol; 2001 Nov; 54(11):1328-31. PubMed ID: 11707244
[TBL] [Abstract][Full Text] [Related]
12. Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report.
Cooray SD; Heerasing NM; Selkrig LA; Subramaniam VN; Hamblin PS; McDonald CJ; McLean CA; McNamara E; Leet AS; Roberts SK
J Med Case Rep; 2018 Jan; 12(1):18. PubMed ID: 29373985
[TBL] [Abstract][Full Text] [Related]
13. An Iron-chelating Agent Improved the Cardiac Function in a Patient with Severe Heart Failure Due to Hereditary Hemochromatosis.
Setoguchi A; Kawano H; Okano S; Honda T; Kato T; Dateki S; Senoo A; Nakashima Y; Motokawa T; Ueno Y; Akashi R; Yonekura T; Sueyoshi E; Ikeda S; Miyazaki Y; Maemura K
Intern Med; 2024 Jan; 63(2):253-258. PubMed ID: 37197964
[TBL] [Abstract][Full Text] [Related]
14. Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients.
Barosi G; Arbustini E; Gavazzi A; Grasso M; Pucci A
Eur J Haematol; 1989 Apr; 42(4):382-8. PubMed ID: 2470615
[TBL] [Abstract][Full Text] [Related]
15. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-1994. A 25-year-old man with the recent onset of diabetes mellitus and congestive heart failure.
N Engl J Med; 1994 Aug; 331(7):460-6. PubMed ID: 8035843
[No Abstract] [Full Text] [Related]
16. Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venesection.
Short EM; Winkle RA; Billingham ME
Am J Med; 1981 Jun; 70(6):1275-9. PubMed ID: 7234894
[TBL] [Abstract][Full Text] [Related]
17. Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.
Das SK; Patel VB; Basu R; Wang W; DesAulniers J; Kassiri Z; Oudit GY
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28115312
[TBL] [Abstract][Full Text] [Related]
18. Early diagnosis of hemochromatosis-related cardiomyopathy with magnetic resonance imaging.
Ptaszek LM; Price ET; Hu MY; Yang PC
J Cardiovasc Magn Reson; 2005; 7(4):689-92. PubMed ID: 16136860
[TBL] [Abstract][Full Text] [Related]
19. Hepatic failure with neonatal tissue siderosis of hemochromatotic type in an infant presenting with meconium ileus. Case report and differential diagnosis of the perinatal iron storage disorders.
Sergi C; Himbert U; Weinhardt F; Heilmann W; Meyer P; Beedgen B; Zilow E; Hofmann WJ; Linderkamp O; Otto HF
Pathol Res Pract; 2001; 197(10):699-709; discussion 711-3. PubMed ID: 11700892
[TBL] [Abstract][Full Text] [Related]
20. Extensive myocardial iron deposition in a patient with hepatitis C.
Rusovici A; Ibrahim S; Sood S; Maher J; Gerula C; Kaluski E; Klapholz M
Tex Heart Inst J; 2012; 39(2):281-3. PubMed ID: 22740754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
